Question 1

Does U.S. Bancorp own AUPH stock?

Accepted Answer

Yes. As of its Q2 2026 13F, U.S. Bancorp holds 12,035 shares of AUPH (Aurinia Pharmaceuticals), worth $204,234.

Question 2

How many shares of AUPH does U.S. Bancorp own?

Accepted Answer

As of its Q2 2026 13F, U.S. Bancorp holds 12,035 shares of AUPH (Aurinia Pharmaceuticals).

Question 3

What is U.S. Bancorp's AUPH position worth?

Accepted Answer

As of its Q2 2026 13F, U.S. Bancorp's AUPH position is worth $204,234.

Question 4

Is U.S. Bancorp buying or selling AUPH?

Accepted Answer

In Q2 2026, U.S. Bancorp increased its AUPH position by 31 shares (+0.3%).

Question 5

When did U.S. Bancorp first buy AUPH?

Accepted Answer

U.S. Bancorp already held AUPH in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	12,035	+0.3%	$204,234	0.0%	$16.97	23
2026-Q1	Increased	12,004	+0.4%	$177,899	0.0%	$14.15	23
2025-Q4	Unchanged	11,960	0.0%	$190,762	0.0%	$15.95	0
2025-Q3	Decreased	11,960	-0.3%	$132,158	0.0%	$11.05	0
2025-Q2	Increased	12,001	+0.2%	$101,648	0.0%	$8.47	22
2025-Q1	Decreased	11,982	-38.1%	$96,335	0.0%	$8.04	0
2024-Q4	Increased	19,366	+61.9%	$173,907	0.0%	$8.98	33
2024-Q3	Increased	11,960	+3.3%	$87,667	0.0%	$7.28	22